Trial Search Results

Magnesium Sulfate vs Placebo for Placental Abruption

To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: Santa Clara Valley Medical Center

Stanford Investigator(s):

Intervention(s):

  • Drug: Magnesium Sulfate
  • Other: Normal Saline

Phase:

N/A

Eligibility


Inclusion Criteria:

- vaginal bleeding and contractions consistent with suspected placental abruption between
24 and 34 weeks gestation.

Exclusion Criteria:

- preterm labor, severe bleeding necessitating immediate delivery, maternal coagulopathy,
fetal distress

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Iris Colon, MD
(408) 855-5550
Not Recruiting